EcoDrugPlus

Folate Hydrolase 1

Ensembl ID : ENSCAFG00020016805
Gene Symbol: FOLH1
3 Cross references
211 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSCAFG00020004601
Gene Symbol: FOLR1
3 Cross references
204 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSCAFG00020026460
Gene Symbol: FSHR
3 Cross references
200 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSCAFG00020019154
Gene Symbol: FFAR1
3 Cross references
76 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSCAFG00020019149
Gene Symbol: FFAR2
3 Cross references
339 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSCAFG00020019726
Gene Symbol: FRK
3 Cross references
217 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSCAFG00020007380
Gene Symbol: GLA
3 Cross references
197 Possible Orthologues:

Galectin 1

Ensembl ID : ENSCAFG00020003738
Gene Symbol: LGALS1
2 Cross references
327 Possible Orthologues:

Galectin 3

Ensembl ID : ENSCAFG00020018232
Gene Symbol: LGALS3
2 Cross references
217 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha1

Ensembl ID : ENSCAFG00020001652
Gene Symbol: GABRA1
3 Cross references
201 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha2

Ensembl ID : ENSCAFG00020002979
Gene Symbol: GABRA2
3 Cross references
201 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha3

Ensembl ID : ENSCAFG00020023233
Gene Symbol: GABRA3
3 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).